- Home
- / ORIC Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ORIC Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$9
2024-10-29
Market Capitalization
$634.9 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| General and administrative expense | 13.4M | 22.0M | 25.1M | 25.6M | 28.8M | 33.2M |
| Operating expense total | 49.3M | 86.8M | 142.9M | 143.0M | ||
| EBIT | (74.2M) | (78.9M) | (91.8M) | (110.8M) | (142.9M) | (143.0M) |
| Interest income | 177.0K | 15.0K | ||||
| Interest expense | 306.0K | 141.0K | 2.6M | |||
| Net Income | (73.7M) | (78.7M) | (89.1M) | (100.7M) | (127.8M) | (129.5M) |
| EPS | (2.2) | (1.0) | (1.8) | (1.5) |